A critical role has been assigned to protein kinase C (PKC)e in the control of intracellular calcium oscillations triggered upon activation of type 5 metabotropic glutamate receptor (mGluR5) in cultured astrocytes. Nevertheless, the physiological significance of this particular signalling profile in the response of astrocytes to glutamate remains largely unknown. Considering that kinases are frequently involved in the regulation of G protein-coupled receptors, we have examined a putative link between the nature of the calcium signals and the response regulation upon repeated exposures of astrocytes to the agonist (S)-3,5-dihydroxyphenylglycine. We show that upon repeated mGluR5 activations, a robust desensitization was observed in astrocytes grown in culture conditions favouring the peak-plateau-type response. At variance, in cell cultures where calcium oscillations were predominating, the response was fully preserved even during repeated challenges with the agonist. Pharmacological inhibition of PKCe or genetic suppression of this isoform using shRNA was found to convert an oscillatory calcium profile to a sustained calcium mobilization and this latter profile was subject to desensitization upon repetitive mGluR5 activation. Our results suggest a yet undocumented scheme in which the activity of PKCe contributes to preserve the receptor sensitivity upon repeated or sustained activations.
Representing the largest cell population in the central nervous system (CNS) of mammalians, astrocytes provide structural, metabolic and trophic support to neurons. Astrocytes also actively participate in the modulation of synaptic activity by releasing a variety of gliotransmitters acting on neuronal receptors and by controlling extracellular concentrations of ions and several neurotransmitters (Eroglu and Barres 2010) . The activities of these glial cells are constantly influenced by changes in their environment as well as by the activity of adjacent neurons (Shao and McCarthy 1994) . Moreover, during nervous pathologies (nerve lesions or neurodegeneration), glial cells show strong adaptation and undergo phenotypic and functional changes (Heneka et al. 2010) .
Accumulating data have demonstrated the essential role played by the amino-acid L-glutamate in the crosstalk between neurons and astrocytes (Santello et al. 2012) . Glutamate is recognized as the major excitatory neurotransmitter in the CNS. It interacts with a variety of glutamate-dependent ion channels (ionotropic glutamate receptors, iGluR) and glutamate-activated G protein-coupled receptors (metabotropic glutamate receptors, mGluR) which are predominantly found on neuron terminals (Yin and Niswender 2014) . However, the presence of mGluRs is also documented in astrocytes from several brain structures and in the spinal cord (D'Antoni et al. 2008 ). So far, major attention was given to the Gq/11-coupled metabotropic glutamate receptor 5 (mGluR5) and the Gi/o-coupled mGluR3, even though their roles in astrocytes remain largely elusive. Yet, accumulating data suggest that mGluR5 would contribute to the glia and neuron interactions by regulating the glial activities in response to the local excitatory tone (Verkhratsky and Kirchhoff 2007; D' Antoni et al. 2008) . Acting as a putative sensor of synaptic glutamate concentration, mGluR5 was also shown to modulate the expression (Aronica et al. 2003 ) and the activity (Vermeiren et al. 2005) of glutamate transporters, likely contributing to the regulation of excitatory transmission and preventing excitotoxic insults.
The cytosolic calcium signals triggered by mGluR5 in astrocytes is characterized by an atypical oscillatory profile (Nakahara et al. 1997) that is faithfully recapitulated when the receptor is heterologously expressed in transfected cell lines (Nash et al. 2002; Bradley et al. 2009 ). This oscillatory signal is, however, not systematically observed upon mGluR5 activation. Depending on cell densities, receptor expression level or external stimuli, single-peak response, peak-plateau response or calcium oscillations can be recorded (Nakahara et al. 1997; Nash et al. 2002; Morita et al. 2003 Morita et al. , 2015 Bradley et al. 2009 ). This indicates that the profile of mGluR5 signalling is subjected to dynamic regulation. Considering the role played by mGluR5 in the control of astrocyte function, one may reasonably propose that the nature of the signalling contributes to a fine-tuning of the astrocyte adaptation to the environment. Previous studies have indeed already shown that distinct intracellular calcium signals may differently affect the regulation of gene transcription (Dolmetsch et al. 1998) .
The particular oscillatory signalling was shown to involve protein kinase C (PKC) that transiently inactivates mGluR5 through reversible phosphorylation of its intracellular C-terminus at position Ser839 (Kawabata et al. 1996; Nakahara et al. 1997; Kim et al. 2005) . In functional assays conducted in primary cultures of astrocytes, a critical role in the control of the oscillatory profile of calcium signalling was further assigned to the novel PKC epsilon (PKCe) isoform (Bradley and Challiss 2011) . The key role played by PKC in driving this rapid but transient form of homologous desensitization somehow contrasts with the sustained homologous desensitization which classically involves specific GPCR kinases. Phosphorylation of the agonist-occupied receptor by these specific kinases promotes the interaction of the receptor with b-arrestins (Kelly et al. 2008 ) that may eventually support subsequent receptor endocytosis (Dale et al. 2002; Dhami and Ferguson 2006) . Hence, GRK2 was demonstrated to phosphorylate mGluR5 on a nearby residue within its intracellular C-terminus (Thr840) and regulate its desensitization and endocytosis in both neurons and transfected cells (Sorensen and Conn 2003; Ribeiro et al. 2009) . Other studies have also demonstrated a role for PKC in the endocytosis or cell trafficking of mGluR5 (Lee et al. 2008; Ko et al. 2012 ) through its phosphorylation of another serine residue (Ser901) in the intracellular terminus.
Homologous receptor desensitization and endocytosis are commonly seen as mechanisms that protect the system against excessive receptor stimulation (Ferguson 2001) . Considering our previous studies showing that astrocytic mGluR5 act as sensors of extracellular glutamate, their desensitization in case of intense/repeated glutamatergic activity would, however, constitute a major shortcoming, as it would preclude further astrocytes/neuronal crosstalk. We therefore hypothesized that the particular oscillatory response associated with mGluR5 is necessary to prevent its desensitization in contexts of sustained glutamatergic activity. We herein demonstrate that astrocytes showing sustained calcium mobilization after mGluR5 activation are subject to robust desensitization, while astrocytes showing calcium oscillations preserve their responsiveness upon repeated stimulations with the agonist. Besides, inhibition of PKCe that converts the mGluR5 oscillatory calcium pattern to sustained calcium mobilization was found to facilitate the desensitization of the receptor. Our results suggest a yet undocumented scheme in which the activity of PKCe contributes to preserve the receptor sensitivity upon repeated or sustained activations.
Materials and methods

Materials
Carbamylcholine chloride (carbachol), poly-L-lysine, the mouse monoclonal anti-glial fibrillary acidic protein-cy3antibody and secondary antibodies goat anti-rabbit and goat anti-mouse IgG were from Sigma Aldrich (Diegem, Belgium). All cell culture reagents (including the G5 supplement) and the Alexa fluor 488 goat anti-rabbit IgG were from Life Technologies (Merelbeke, Belgium). (S)-3,5-dihydroxyphenylglycine (DHPG), Ro 31-8220, G€ o 6976, FR 236924 and 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine were purchased from Tocris (Bristol, UK). Fura2-acetoxymethyl ester was from Molecular Probes (Asse, Belgium). The rabbit anti-mGluR5 antibody was purchased from Upstate (Biognost, Heule, Belgium). The mouse PKCe antibody was obtained from BD Bioscience (Erembodegem, Belgium). The DC Protein Assay Reagents Package for protein dosage was from BioRad Laboratories (Nazareth, Belgium) and the chemiluminescence reagents for immunoblots were purchased from PerkinElmer NEN (Zaventem, Belgium). The Percoll TM /(GE Healthcare BioScience AB, Uppsala, Sweden) reagent was purchased from GE Healthcare (Uppsala, Sweden). Culture plasticwares were obtained from Greiner Bio-One (Wemmel, Belgium).
Animals and ethics statement
All experiments were conducted on primary cultures derived from Sprague-Dawley rat pups in strict adherence to the EU directive of 22/09/2010 (2010/63/EU). Pups were obtained by breeding adult rats obtained from Charles River Laboratories (Brussels, Belgium). There was no blinding, and two or three animals per litter were randomly chosen for setting up each culture. The sex of the animals used for cultures was unknown. The ethical committee of the Universit e catholique de Louvain for animal experiments specifically approved this study, which received the agreement number 2014/UCL/MD/012. Our laboratory received agreement number LA 1230297 from the Ministry of Agriculture. All animals used for breeding were housed in cages that provided an environment with controlled light/dark cycles, temperature and humidity. Every effort was made to minimize the number of animals used in this study and to minimize suffering during the manipulations, and pups were killed by decapitation.
Primary cultures of cortical rat astrocytes
Cortices from rat pups were collected at postnatal day 2 and mechanically dissociated. Astrocytes were separated from other cell types using a 30% Percoll solution and were seeded into gelatin-coated flasks. Cells were left to proliferate for 14 days at 37°C in a humidified atmosphere containing 5% CO 2 in Dulbecco's modified Eagle's medium (glutaMAX) supplemented with 10% foetal bovine serum (FBS), 50 mg/mL penicillin-streptomycin and 50 mg/mL fungizone. On day 7, the medium was renewed, and on day 14 cells were trypsinized, counted and plated in Dulbecco's modified Eagle's medium (glutaMAX) supplemented with 10% FBS. After 2 days, FBS was reduced to 3% and the medium was supplemented or not with G5. All experiments were then conducted 7 days later.
Immunocytochemistry
Astrocytes grown on poly-L-lysine-coated 12 mm round glass coverslips were fixed with 95% ethanol for 15 min at 20°C. Thereafter, astrocytes were permeabilized with 1% Triton X-100 (v/ v) in phosphate-buffered saline (PBS) (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na 2 HPO 4 , 1.47 mM KH 2 PO 4 , pH 7.4). Non-specific immunostaining was prevented by incubation for 1 h in a PBS solution containing 3% non-fat dry milk at 20°C. Fixed astrocytes were then incubated in PBS/3% milk overnight at 4°C with the primary antibody rabbit anti-mGluR5 (1/500) and the mouse antiPKCe (1/500). The next day, astrocytes were rinsed three times with PBS and were incubated for 1 h with the secondary antibody goat anti-rabbit Alexa fluor 488 (1/500) and the goat anti-mouse Alexa fluor 555 (1/500). After three last rinses, preparations were mounted in Fluoprep medium and were analysed using a fluorescent inverted microscope (EVOS fl, AMG, Westburg, Leusden, the Netherlands). 
Subcellular fractionation
Astrocytes were plated on six-well plates and washed once with serum-free medium and suspended in 1 mL of serum-free medium on ice. Cells were then centrifuged for 5 min at 1700 g. Supernatant was eliminated and cells were suspended with a lysis buffer (1 M EDTA, 1 M imidazole, 1 M sucrose adjusted to pH 7) supplemented with a cocktail of protease inhibitors and mechanically homogenized by repeated passages through a 26 gauge syringe needle. The total lysate was centrifuged for 10 min at 250 g at 4°C and the resulting supernatant was then centrifuged at 100 000 g for 30 min in a Beckman L8-70M ultracentrifuge. The pellet, corresponding to the membrane fraction, was suspended in Laemmli buffer (125 mM Tris pH 6.8, 20% glycerol, 4% sodium dodecyl sulphate). The supernatant corresponding to the cytosolic fraction was precipitated by addition of trichloroacetate (10% final concentration) and incubated for 30 min on ice. After a centrifugation of 5 min at 15 000 g, the pellet was resuspended in Laemmli buffer. Both cytosolic and membrane fractions were used in immunoblotting experiments.
Immunoblotting
Astrocytes were seeded in six-well plates, rinsed with PBS and scraped in ice-cold lysis buffer (TrisHCl 10 mM, pH 7.4, ethylene diamine tetraacetic acid 1 mM, ethylene glycol tetraacetic acid 10 mM, DL-dithiotreitol 2 mM, Igepal-NP40 1%, glycerol 20%). Samples were collected and then centrifuged at 1000 g for 3 min to remove insoluble material. Protein concentration was determined using the DC Protein Assay Reagents Package and samples were diluted in a loading buffer (TrisHCl 125 mM pH 6.8, glycerol 20%, sodium dodecyl sulphate 4% and bromophenol blue 0.01%) and boiled for 5 min. Samples were electrophoresed through a 10% sodium dodecyl sulphate-polyacrylamide gel electrophoresis and transferred to nitrocellulose membrane by electroblotting. Membranes were incubated 1 h in Tris-buffered saline (TBS-Tris 50 mM pH 7.4, NaCl 150 mM) containing 0.05% Tween-20 and 5% non-fat milk to reduce non-specific labelling. Immunoprobing was carried out by incubating membranes overnight at 4°C with primary antibodies rabbit anti-mGluR5 (1/1200), mouse anti-PKCe (1/1000) and rabbit anti-GAPDH (glyceraldehyde-3-phosphate dehydrogenase) (1/30 000). Membranes were then incubated 1 h at 20°C with peroxidase-conjugated secondary antibodies goat anti-rabbit IgG (1/ 3000) and goat anti-mouse IgG (1/2000). Immunoreactive proteins were detected with enhanced chemiluminescence reagent followed by autoradiography. Densitometric analysis of protein signals were performed using ImageJ (Broken Symmetry Software).
Construction of lentiviral vectors and cells transduction
shRNA sequences targeting the rat pkce (CCCTTATCTAACC-CAACTCT and CGTCACTTCGAGGACTGGATT) transcripts were selected using the RNA mission collection (Sigma, St Louis, MO, USA). They were cloned in pMK117 (Kreit et al. 2015) using BshTI and EcoRI. This construct also harbours the gene encoding for the fluorescent protein E2-Crismon, facilitating the detection of infected cells. Lentiviral particles were produced by calcium phosphate transfection of 293T cells with 15 lg of lentiviral vectors, 11.25 lg of pSPAX2 (Addgene, Cambridge, Massachusetts, USA) and 4.5 lg of pMD2-VSV-G. Lentiviral particles in supernatant were collected 24 and 48 h post transfection, passed through a 0.45 lm filter and concentrated 10 times using Vivaspin columns (cutoff: 1 000 000 Da; Vivaspin, Sartorius, Goettingen, Germany). The produced lentiviral particles were titrated by flow cytometry. Briefly, 10 000 cells were seeded and transduced with dilutions of lentivirus. Percentages of E2-Crimson-positive cells were measured and used to transduce about 90% of mammalian cells (tested in HEK293 cells -human embryonic kidney cells).
Statistical analyses
Data were expressed as means with SEM and statistical analyses were performed using GraphPad Prism version 5.03 (GraphPad Software Inc., San Diego, CA, USA). Differences in experimental data among two different groups were evaluated with Student's ttest. Analysis of variance between multiple groups were conducted through a one-way ANOVA followed by a Dunnett's test for multiple comparisons to compare all different condition to the control group. In all statistical analyses, a value of p < 0.05 was defined as significant.
Results
mGluR5 expression and function in rat cortical astrocytes
The expression and functional properties of mGluR5 in primary cultured astrocytes were examined after maturation of the cells for 1 week in medium containing 3% serum and in the presence or in the absence of the culture supplement G5. Decreasing the concentration of serum gave rise to astrocytes adopting a protoplasmic phenotype (Fig. 1a) . Cells exposed to the culture supplement G5 that essentially contains growth factors adopted the typical morphology of stellate astrocytes.
Immunostaining for mGluR5 revealed a higher expression of the receptor in stellate astrocytes compared to protoplasmic astrocytes. Such difference in mGluR5 expression was confirmed by immunoblotting studies revealing a threefold higher signal in the G5-supplemented cultures as compared to control (no G5 supplement) (Fig. 1b) . The mGluR5-mediated cytosolic calcium mobilization in astrocyte cultures was examined by exposing the cells to the specific group I mGluR agonist DHPG. Both protoplasmic and stellated astrocytes showed robust intracellular calcium increases upon application of 50 lM DHPG. However, the response profiles appeared considerably different as protoplasmic cells showed an initial peak followed by sustained and progressively decreasing intracellular calcium concentration (Fig. 2a) . Approximately, 80% of cells showed this sustained and persistent calcium mobilization, while 20% did not respond to the mGluR5 agonist (Fig. 2c) . In contrast, activation of mGluR5 with DHPG in stellate astrocytes led to repeated calcium oscillations in the vast majority (80%) of responding cells (Fig 2b) with an oscillation frequency of up to 10-12 peaks per min (Fig. 2d) . This frequency was influenced by the agonist concentration After normalization to GAPDH expression, data were shown as relative to the signal obtained with protoplasmic astrocytes non-exposed to DHPG. GF, Growth factors. Statistical analyses were performed through a oneway ANOVA followed by a Dunnett's multiple comparison test (*p < 0.05, **p < 0.01, ***p < 0.001 and n.s.: no significant differences).
as increasing DHPG concentration from 1 to 200 lM also increased the calcium oscillation frequency from an average of 3-10 peaks per min (see below and in Fig. 3d ). There was no evidence for synchronous oscillation between neighbouring cells. In both cultures, the response rapidly faded upon removal of DHPG. DHPG is an agonist of group I mGluR, activating both mGluR1 and mGluR5. As shown on Fig. 2e and f, the calcium response in both protoplasmic and stellate astrocytes was totally abolished when assayed in the presence of 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine, a specific mGluR5 antagonist, confirming the sole implication of this receptor subtype in the response to DHPG.
Previous studies have highlighted the importance of PKCe activity in the control of mGluR5-mediated calcium signalling. Both, protoplasmic and stellate astrocytes were stained for PKCe without noticeable differences (Fig. 1a) . Accordingly, immunoblotting studies revealed that the expression of this PKC isoform did not differ between the two types of astrocyte cultures (Fig. 1c) . The subcellular distribution of PKCe in astrocytes was examined after cell fractionation followed by analysis of membrane and cytosolic fractions by immunoblotting. Cells grown in the presence or in the absence of the G5 supplement showed similar PKCe expression level in the cytosolic (Fig. 2g ) and membrane fraction (Fig. 2h) . Exposing both cultures to DHPG resulted in a substantial membrane translocation of PKCe, witnessing its efficient activation by mGluR5 ( Fig. 2g and h ).
Desensitization of DHPG-induced calcium mobilization
The functional properties of mGluR5 in cultured astrocytes were further studied by examining the response to three successive exposures to DHPG for 1 min separated by 1-min washout periods (Fig. 3a and b) . In astrocytes matured in the presence of 3% FBS only, successive stimulations with 1 lM DHPG led to a modest but systematic decline in the intensity of the second and third calcium peaks and associated plateau. At a higher DHPG concentration (10 lM), the amplitude of the responses to the second and third stimuli was decreased as compared to the initial response. This desensitization was even more pronounced with 50 and 200 lM of DHPG. Noteworthy, the calcium signal during the plateau phase observed upon the first stimulation with DHPG tended to gradually decline when testing the highest concentrations of the agonist, which was here also interpreted as desensitization. In contrast, stellate astrocytes appeared resistant against desensitization. Thus, successive application of DHPG on cells grown in the presence of the G5 supplement was found to elicit calcium mobilization with the typical stable oscillatory profile that was only weakly reduced in the second and third stimulations, even when DHPG was tested at the highest concentration (200 lM) (Fig. 3b) . Interestingly, while the vast majority of the astrocytes grown in the presence of the G5 supplement showed the oscillatory-type response, a few isolated cells showed a peak-plateau-type response and were subjected to desensitization (Fig. 3c) . The importance of mGluR5 desensitization was further examined by comparing the amplitude of the immediate peak observed upon each successive application of DHPG as well as by comparing the area under the curve during the three exposures to DHPG. These quantitative data confirmed that when protoplasmic astrocytes were exposed to 50 lM DHPG, a significant decline in the calcium signal is observed (Fig. 3e and f) , while no such differences were observed in stellate astrocytes ( Fig. 3g and h ). Similar observations were obtained when DHPG was tested at 1, 10, and 200 lM (see Data S1).
It was previously reported that exposing astrocytes to growth factors could alter the calcium stores capacity (Morita et al. 2003) . Therefore, in order to verify that the decline in calcium mobilization upon repeated stimulations in protoplasmic astrocytes was not simply reflecting calcium store depletion, we exposed astrocytes to ATP (100 lM) after three successive stimulations with DHPG (50 lM). In these conditions, the purinergic receptor agonist efficiently triggered intracellular calcium mobilization (Fig. 4a) . This response was similar to the response observed in cells that were not previously challenged with DHPG (Fig 4b) . Indeed, no differences were observed when comparing the amplitude of the immediate peak or the area under the curve upon stimulation with ATP ( Fig. 4c and d) . These data suggest that the decline in the DHPG-induced calcium signalling was not caused by calcium store depletion (Fig. 4b) . Fig. 3 Desensitization of mGluR5-mediated calcium signalling. Protoplasmic [a, matured in foetal bovine serum (FBS)3%] and stellate astrocytes (b, matured in FBS3% with G5 supplement) were exposed three times during 60 s to 1, 10, 50 and 200 lM (S)-3,5-dihydroxyphenylglycine (DHPG). After each exposure to DHPG, astrocytes were perfused for 60 s without DHPG. Traces are representative from 4 to 6 cells and the experiment was repeated at least four times with similar results. A representative trace from a single occasional non-oscillating astrocyte in a culture of astrocytes showing oscillation is showed in panel (c) (black line). The frequency of calcium oscillations in stellate astrocytes was quantified (d) and is expressed as number of peaks per min. The calcium response in astrocytes matured in the absence (e and f) or presence (g and h) of the G5 supplement was further monitored by measuring the area under the curve in three successive stimulations with 50 lM of DHPG as well as the amplitude of the initial peak, observed immediately after exposure to DHPG. Histograms show means with SEM of data from four different experiments and are normalized to the response during the first application of DHPG. Statistical analyses were performed through a one-way ANOVA followed by a Dunnett's multiple comparison test (**p < 0.01, ***p < 0.001, n.s.: significant difference). Effect of altering PKCe activity on mGluR5-mediated calcium responses To analyse the role of PKC in defining the profile of calcium signalling in response to mGluR5 activation, astrocyte cultures were pre-incubated with selected PKC inhibitors and then exposed repeatedly to DHPG (50 lM). Inhibition of all PKC isoforms with the large spectrum inhibitor Ro 31-8220 in stellate astrocytes, converted the calcium oscillatory profile induced by DHPG to a peak-plateau profile (Fig. 5a ). In these conditions, repeated exposures to DHPG were found to trigger a rapid decline in the amplitude of the calcium response and a reduction in the area under the curve ( Fig. 5b and c) . These data indicate that the loss of an oscillatory profile type response concurred with the establishment of desensitization of mGluR5 signalling. The role of PKCe was more specifically investigated using the inhibitor G€ o 6979 which discriminates between calcium-dependent and calcium-independent PKC isoforms. In stellate cells preexposed to compound G€ o 6979, more than 80% of the cells showed robust calcium oscillations after stimulation with DHPG and these were preserved during repeated challenges with the agonist (Fig. 5d) . While a progressive but modest decline in the amplitude of the initial peak was observed upon successive exposures to DHPG (Fig. 5e ), no significant differences were evidenced when considering the area under the curve (Fig. 5f ). The influence of the two inhibitors was also examined on protoplasmic astrocytes where no differences in calcium signals were observed between treated and non-treated cells (data not shown).
To further explore the specific implication of PKCe in the regulation of mGluR5 signalling, a lentivirus encoding for a specific shRNA against PKCe was designed. Astrocytes were infected during 4 days with scrambled-shRNA-lentiviruses or PKCe-shRNA-lentiviruses. Fluorescent detection of the E2-Crimson protein in infected cells revealed a high infection efficiency with approximately 98.5% AE 2.0 positive cells (data not shown). Cell infection with either scrambledshRNA or PKCe-shRNA-lentiviruses did not cause any change in the astrocyte morphology or in the expression of mGluR5 (data not shown). The efficiency of the silencing approach was confirmed by immunoblotting experiments revealing a 47.9% AE 6.0 decrease in PKCe expression level in PKCe-shRNA-lentivirus infected cultures compared to non-infected samples. In contrast, no difference was observed with the scrambled-shRNA-lentivirus (Fig. 6c) . As in non-infected cultures, stellate astrocytes infected with a scrambled-shRNA-lentivirus showed robust calcium oscillations after exposure to DHPG (Fig. 6a and d) no sign of desensitization upon repeated stimulations ( Fig. 6g and h ). In contrast, the response in stellate astrocytes infected with the PKCe-shRNA-lentivirus was heterogeneous, revealing a substantial decrease in the proportion of cells showing calcium oscillations ( Fig. 6b and d) . Cells adopting the peak-plateau profile showed robust desensitization upon repeated stimulation ( Fig. 6e and f) , whereas cells showing calcium oscillation were resistant against desensitization ( Fig. 6i and j) . Finally, the influence of PKCe was also indirectly examined using the specific activator FR 236924 (0.1-1 mM) (Fig. 7) . In stellate astrocytes, activation of PKCe caused a concentration-dependent decrease in the proportion of cells showing an oscillatory-type response upon DHPG application (Fig. 7c) . Thus, after pre-incubation with FR 236924 at the highest concentration tested (1 mM), only a modest (20%) proportion of cells showed calcium oscillations upon challenge with DHPG (p < 0.001) (Fig. 7c) . Activation of PKCe also tended to decrease the DHPGevoked calcium oscillation frequency (Fig. 7d) . Also worth mentioning was the concentration-dependent increase in nonresponding cells (up to 15% at 1 mM FR 236924, p < 0.01) (Fig. 7c) . In the repeated stimulation paradigm, cells pretreated with the PKCe activator at a low concentration did not show desensitization (Fig. 7a) . In contrast, cells pretreated with the PKCe activator at the highest concentration tested tended to desensitize, as evidenced by a larger proportion of astrocytes showing transient calcium mobilization with subsequent decreased peak intensity and decreased area under the curve (data not shown) (Fig. 7b ).
Discussion
While a large diversity of glutamate receptors has been characterized in the CNS, cortical astrocytes predominantly express the mGluR5 which is considered to be a key astrocyte sensor of extracellular glutamate (Porter and McCarthy 1996; Nicoletti et al. 1999; Vermeiren et al. 2005) . Studies have shown that activation of mGluR5 modulates astrocytic cell proliferation (Kanumilli and Roberts 2006) , increases glutamate uptake capacity (Aronica et al. 2003; Vermeiren et al. 2005) , promotes the release of brain-derived neurotrophic factor as well as gliotransmitters such as ATP and D-serine (Zorec et al. 2012 ) and modulates inflammatory responses (Shah et al. 2012) . Thereby, mGluR5 is thought to contribute to the regulation of synaptic activity and to modulate neuronal growth, neuroprotection and excitotoxicity (Viwatpinyo and Chongthammakun 2009) . Considering a preferential coupling with Gq/11-type G proteins, intracellular calcium mobilization is likely involved in the molecular signalling pathway linking the activation of mGluR5 and the regulation of glial activities. However, the importance of the dynamic pattern of the calcium signal in the control of these glial responses remains largely unexplored. We have previously proposed that the shift from an oscillatory profile of mGluR5 signalling to a peak-plateau profile in astrocytes from hSOD1
G93A animals (transgenic model for amyotrophic lateral sclerosis) was The amplitude of the initial peaks and the areas under the curve were quantified in both conditions and expressed as mean with SEM of data from four different experiments, relative to the response observed during the first application of DHPG. Statistical analyses were performed through a one-way ANOVA followed by a Dunnett's test for multiple comparisons (** and ***p < 0.01 and p < 0.001, n.s.: no significant difference).
correlated with a loss of mGluR5-mediated regulation of glutamate transporters (Vermeiren et al. 2006) . The molecular mechanisms supporting the oscillatory profile of the intracellular calcium signalling associated with mGluR5 in astrocytes has received considerable attention during the last two decades. Thus, the transient and repetitive PKC-mediated phosphorylation of a single serine residue within the intracellular c-terminus of the receptor has been identified as a pivotal control of the signalling cascade (Kawabata et al. 1996) . This particular oscillatory profile was shown to be influenced by extracellular stimuli, including inflammatory mediators and growth factors (in particular EGF (Epidermal growth factor) and bFGF (basic fibroblast growth factor)) (Morita et al. 2003) and also by the shRNA-lentivirus are measured for the three DHPG stimulations. For analyses, matured astrocytes infected with PKCe-shRNA-lentiviruses were subclassified into cells that show a peak-plateau-type response (e and f) and cells showing calcium oscillations (i and j). The amplitude of the initial peaks and the areas under the curve were quantified in both conditions and expressed as mean with SEM of data from four different experiments relative to the response observed during the first application of DHPG. Statistical analyses were performed through a one-way ANOVA followed by a Dunnett's test for multiple comparisons (***p < 0.001 and n.s.: significant difference).
density of the mGluR5 (Nash et al. 2002) . Indeed, Nash et al. (2002) showed that inducing the mGluR5 expression in transfected cells increased the number of cells showing calcium oscillations upon mGluR5 activation. The distinct mGluR5 expression level observed in protoplasmic or stellate astrocytes reported here could explain the oscillatory pattern of the latter, even though the expression of PKCe was similar. Nevertheless, the role and physiological implications of these oscillations in astrocytes remain largely unknown. The mGluR5 likely contributes to the astrocytic adaptation during excitatory synaptic activity, and one may expect that the nature of the signalling would impact the astrocytic response. We here postulated that at variance with a conventional sustained elevation of intracellular calcium observed during phospholipase C activation, the transient calcium elevations that shapes the oscillatory profile would support efficient and sustained signalling without triggering receptor desensitization. This was suggested by the observation that astrocytes maintained in growth factor-free conditions during their maturation and exposed to the mGluR5 agonist DHPG essentially showed a peak of intracellular calcium concentration followed by a plateau-type response which progressively declined during sustained stimulation. Upon repeated exposures to DHPG, this cell response was considerably decreased, indicating a rapid desensitization of mGluR5. In contrast, astrocytes grown in the presence of a defined cocktail of growth factors adopted the oscillatorytype response after mGluR5 activation which was resistant against desensitization, even after repetitive challenges with DHPG. Convincingly, the pharmacological inhibition of PKCe activity or the specific reduction in PKCe expression with a specific PKCe-shRNA-lentivirus converted the oscillatory profile into a peak-plateau-type response (Bradley and Challiss 2011) which was accompanied by the establishment of a desensitizing pattern, clearly evidenced by the declining response upon repeated challenges. These observations are consistent with the data reported by Morita et al. (2015) showing that inhibition of PKC by a series of pharmacological inhibitors converts astrocytic calcium signalling from an oscillatory to a sustained or non-oscillatory calcium response (Morita et al. 2015) . Moreover, cells exposed to a selective PKCe activator also showed a loss of calcium oscillations and exhibited progressive desensitization. This latter observation indicates that a persistent activation of this kinase precludes the repetitive on-and-off switch of the signalling cascade. Together, these data suggest that a tight regulation of PKCe activity is required to preserve oscillations as well as to prevent desensitization. Besides, our experiments conducted on astrocytes matured in the presence of growth factors showed that the alteration of mGluR5 density is not sufficient to explain the changes in calcium signalling. The desensitization of GPCR kinases is classically viewed as a key regulatory mechanism that protects against excessive receptor stimulation (Ferguson 2007) . This was indeed evidenced for mGluR1 where desensitization was shown to protect against glutamate-mediated cell apoptosis (Dale et al. 2000) . At the molecular level, the process is often initiated by receptor phosphorylation by GRK or by second messengerdependent protein kinases in case of homologous or heterologous desensitization respectively. The role of GRKs in the regulation of mGluRs has been previously examined. In the second group of mGluRs, only mGluR3 appears desensitized by GRK2 activation, whereas mGluR2 is unaffected by any GRKs (Iacovelli et al. 2009 ), suggesting its resistance against homologous desensitization. Similarly mGluR4 was shown to desensitize or internalize through a PKC-dependent mechanism but not through GRKs (Mathiesen and Ramirez 2006). GRK2 was also shown to contribute to the phosphorylation and desensitization of both mGluR1 and mGluR5 in HEK cells, but paradoxically, more recent studies have shown that mGluR5 desensitization by GRK2 was phosphorylation-independent in HEK cells and neurons (Ribeiro et al. 2009; Zhang et al. 2013) . With respect to mGluR5, both PKA (Protein Kinase A) and PKC were shown to phosphorylate mGluR5, influencing the cellular internalization of the receptor upon prolonged (30 min) exposure to the agonist DHPG (Lee et al. 2008; Uematsu et al. 2015) . Schwendt and Olive's recent finding is worth mentioning because it revealed that PKCe activity could participate in the control of mGluR5 internalization in neurons of the nucleus accumbens, even though there was no evidence for the phosphorylation of the receptor itself (Schwendt and Olive 2017) . Together with the present observation, these data highlight the key roles played by this specific PKC isoform on the desensitization and internalization of mGluR5.
Our present study adds another facet to the role of PKC in the regulation of mGluR5. At variance with the concept that phosphorylation triggers a cascade of molecular mechanisms leading to the desensitization and internalization/endocytosis of cell surface receptors, we here propose that the repetitive and transient receptor inactivation contributes to achieving efficient and preserved intracellular signalling by preventing the loss of receptor function. The activity of the non-conventional PKCe isoform appears specifically involved in this control of mGluR5 regulation and physiological or pathological modulations of this kinase could directly influence the adaptation of astrocytes to extracellular glutamate levels.
In summary, we showed that the oscillatory profile of the calcium signalling triggered upon activation of mGluR5 in stellate astrocytes prevents the desensitization of the receptor. In the context of intense synaptic excitatory activity, this could be seen as a physiological mechanism that preserves the mGluR5 mediated control of astrocyte functions that contributes to the neuroprotective roles played by these glial cells. Considering the specific role of PKCe in the control of calcium oscillations, further studies should consider the alteration of PKC isoform specifically in astrocytes during the course of nervous disorders and validate the link with an impaired adaptation of astrocyte function in response to the pathological environment.
